default author photo

Michael Andreeff

University of Texas at Houston - MD Anderson Cancer Center

1515 Holocombe Blvd

Unit 1905

Houston, TX 77030

United States

SCHOLARLY PAPERS

1

DOWNLOADS

45

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

A Phase II Study of Omacetaxine Mepesuccinate for Patients with Higher-Risk Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia after Failure of Hypomethylating Agents

Number of pages: 56 Posted: 19 Jul 2018
Nicholas James Short, Elias Jabbour, Kiran Naqvi, Ami Patel, Jing Ning, Koji Sasaki, Graciela Nogueras Gonzalez, Prithviraj Bose, Steven Kornblau, Koichi Takahashi, Michael Andreeff, Gabriela Sanchez-Petitto, Zeev Estrov, Courtney Dinardo, Guillermo Montalban-Bravo, Marina Konopleva, Yesid Alvarado, Kapil Bhalla, Warren Fiskus, Maria Khouri, Rabiul Islam, Hagop Kantarjian and Guillermo Garcia-Manero
University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Leukemia and University of Texas at Houston - Department of Leukemia
Downloads 45 (1,133,231)

Abstract:

Loading...

Myelodysplastic syndromes, chronic myelomonocytic leukemia, hypomethylating agents, omacetaxine mepesuccinate, homoharringtonine